Bank of America
TVGNW icon

Bank of America’s Tevogen Inc. Warrant TVGNW Stock Holding History

Bank of America’s Portfolio TVGNW Stock Details TVGNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-121
Closed -$1 – 8459
2024
Q3 		$1 Sell
121
-100
-45% -$2 ﹤0.01% 8136
2024
Q2 		$3 Hold
221
– – ﹤0.01% 8150
2024
Q1 		$18 Buy
+221
New +$13 ﹤0.01% 7505

Other funds holding TVGNW

HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
GCM
Greenland Capital Management New York $787M AUM 40.68% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return

Bank of America's TVGNW Position: Q4 2024 in Review

Bank of America sold out of Tevogen Inc. Warrant (TVGNW) in Q4 2024, closing a stake of 121 shares — an estimated $1 sold.

Bank of America first reported a position in TVGNW in Q1 2024 and held it in 3 quarters. The position peaked at $18 in Q1 2024. 36 funds tracked by Wall St. Rank hold TVGNW as of Q4 2024.

  • Bank of America reported no remaining Tevogen Inc. Warrant position as of Q4 2024 after selling out during the quarter.
  • Bank of America sold 121 Tevogen Inc. Warrant shares in Q4 2024, an estimated $1.
  • Bank of America first reported a position in Tevogen Inc. Warrant in Q1 2024 and held it in 3 quarters.
  • Bank of America's Tevogen Inc. Warrant position peaked at $18 in Q1 2024.
  • 36 funds tracked by Wall St. Rank held Tevogen Inc. Warrant as of Q4 2024.

Based on Bank of America's 13F filing for Q4 2024, filed 14 Feb 2025.